BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27348280)

  • 1. Evaluation of Comprehensive Medication Review Completion Rates Using 3 Patient Outreach Models.
    Miller DE; Roane TE; Salo JA; Hardin HC
    J Manag Care Spec Pharm; 2016 Jul; 22(7):796-800. PubMed ID: 27348280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.
    Miguel A; Hall A; Liu W; Garrett J; Ballew A; Yang TH; Segal R
    J Manag Care Spec Pharm; 2017 Jan; 23(1):13-21. PubMed ID: 28025924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Medication Reviews in Long-term Care Facilities: History of Process Implementation and 2015 Results.
    O'Shea TE; Zarowitz BJ; Erwin WG
    J Manag Care Spec Pharm; 2017 Jan; 23(1):22-26. PubMed ID: 28025922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive Medication Changes Resulting from Comprehensive and Noncomprehensive Medication Reviews in a Medicare Part D Population.
    Buhl A; Augustine J; Taylor AM; Martin R; Warholak TL
    J Manag Care Spec Pharm; 2017 Mar; 23(3):388-394. PubMed ID: 28230451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.
    Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multichannel Medication Adherence Intervention Influences Patient and Prescriber Behavior.
    Leslie RS; Gilmer T; Natarajan L; Hovell M
    J Manag Care Spec Pharm; 2016 May; 22(5):526-38. PubMed ID: 27123914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures.
    Leslie RS; Tirado B; Patel BV; Rein PJ
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1193-203. PubMed ID: 25443513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Influence of a Community Pharmacy Automatic Prescription Refill Program on Medicare Part D Adherence Metrics.
    Lester CA; Mott DA; Chui MA
    J Manag Care Spec Pharm; 2016 Jul; 22(7):801-7. PubMed ID: 27348281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Medication Therapy Management Services and Their Effects on Health Care Utilization and Medication Adherence.
    Ferries E; Dye JT; Hall B; Ndehi L; Schwab P; Vaccaro J
    J Manag Care Spec Pharm; 2019 Jun; 25(6):688-695. PubMed ID: 31134865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Plan Type and Comprehensive Medication Reviews on High-Risk Medication Use.
    Almodovar AS; Axon DR; Coleman AM; Warholak T; Nahata MC
    J Manag Care Spec Pharm; 2018 May; 24(5):416-422. PubMed ID: 29694292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of the Comprehensive Medication Review Completion Rate for Medicare Part D Plans: What Do the Stars Tell Us?
    Cooke CE; Olshanskaya S; Lee M; Brandt NJ
    Sr Care Pharm; 2022 Aug; 37(8):357-365. PubMed ID: 35879850
    [No Abstract]   [Full Text] [Related]  

  • 12. Discrepancies identified with the use of prescription claims and diagnostic billing data following a comprehensive medication review.
    Roane TE; Patel V; Hardin H; Knoblich M
    J Manag Care Pharm; 2014 Feb; 20(2):165-73. PubMed ID: 24456318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do comprehensive medication review completion rates predict medication use and management quality?
    Wang Y; Farley JF; Ferreri SP; Renfro CP
    Res Social Adm Pharm; 2019 Apr; 15(4):417-424. PubMed ID: 30917893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool.
    Mhatre SK; Serna O; Sansgiry S; Fleming ML; Essien EJ; Sansgiry SS
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1293-1301. PubMed ID: 27783546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Medication Review Completion Rates and Disparities After Medicare Star Rating Measure.
    Hung A; Wilson L; Smith VA; Pavon JM; Sloan CE; Hastings SN; Farley J; Maciejewski ML
    JAMA Health Forum; 2024 May; 5(5):e240807. PubMed ID: 38700854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Clinical and Attitudinal Characteristics on Obtaining Comprehensive Medication Reviews.
    Farris KB; Salgado TM; Aneese N; Marshall VD; Pendergast JF; Frank J; Chrischilles EA; Doucette WR
    J Manag Care Spec Pharm; 2016 Apr; 22(4):388-95. PubMed ID: 27023692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is There a Relationship Between Part D Medication Adherence and Part C Intermediate Outcomes Star Ratings Measures?
    Ta JT; Erickson SC; Qiu WA; Patel BV
    J Manag Care Spec Pharm; 2016 Jul; 22(7):787-95. PubMed ID: 27348279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication Therapy Management: 10 Years of Experience in a Large Integrated Health Care System.
    de Oliveira DR; Brummel AR; Miller DB
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1057-1066. PubMed ID: 32857651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of an Advanced Pharmacy Practice Experience on Medication Therapy Management Services in a Centralized Retail Pharmacy Program.
    Vande Griend JP; Rodgers M; Nuffer W
    J Manag Care Spec Pharm; 2017 May; 23(5):561-565. PubMed ID: 28448777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Patients Know About Services to Help Manage Chronic Diseases and Medications: Findings from Focus Groups on Medication Therapy Management.
    Taylor AM; Axon DR; Campbell P; Fair MK; Nelson M; Boesen K; Martin R; Warholak TL
    J Manag Care Spec Pharm; 2018 Sep; 24(9):904-910. PubMed ID: 30156456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.